MétaCan
← tous les travaux

Broad targeting of resistance to apoptosis in cancer

2015· review· en· 846 citations· W2072860434 sur OpenAlex· 10.1016/j.semcancer.2015.03.001

Pourquoi ce travail est-il dans la base ?

Une base qui oublie comment elle a trouvé un travail ne peut pas être vérifiée. Voici les voies qui ont admis celui-ci.

Organisme subventionnaire canadienUn organisme canadien l'a financé. Le travail peut ne porter aucune affiliation canadienne.

Aucune affiliation canadienne. Une base fondée sur la seule affiliation (le devis habituel) n'aurait jamais vu ce travail. C'est l'un des travaux qui justifient l'inversion de la base.

Résumé

Apoptosis or programmed cell death is natural way of removing aged cells from the body. Most of the anti-cancer therapies trigger apoptosis induction and related cell death networks to eliminate malignant cells. However, in cancer, de-regulated apoptotic signaling, particularly the activation of an anti-apoptotic systems, allows cancer cells to escape this program leading to uncontrolled proliferation resulting in tumor survival, therapeutic resistance and recurrence of cancer. This resistance is a complicated phenomenon that emanates from the interactions of various molecules and signaling pathways. In this comprehensive review we discuss the various factors contributing to apoptosis resistance in cancers. The key resistance targets that are discussed include (1) Bcl-2 and Mcl-1 proteins; (2) autophagy processes; (3) necrosis and necroptosis; (4) heat shock protein signaling; (5) the proteasome pathway; (6) epigenetic mechanisms; and (7) aberrant nuclear export signaling. The shortcomings of current therapeutic modalities are highlighted and a broad spectrum strategy using approaches including (a) gossypol; (b) epigallocatechin-3-gallate; (c) UMI-77 (d) triptolide and (e) selinexor that can be used to overcome cell death resistance is presented. This review provides a roadmap for the design of successful anti-cancer strategies that overcome resistance to apoptosis for better therapeutic outcome in patients with cancer.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

La notice

Revue
Seminars in Cancer Biology
Thématique
Cell death mechanisms and regulation
Domaine
Biochemistry, Genetics and Molecular Biology
Établissements canadiens
Organismes subventionnaires
National Institute of Neurological Disorders and StrokeNational Institute on Deafness and Other Communication DisordersTerry Fox FoundationNational Institutes of HealthMinistry of Science and Technology, TaiwanNational Cancer InstituteMinistero dell’Istruzione, dell’Università e della RicercaNational Institute on Minority Health and Health DisparitiesNational Center for Research ResourcesTaipei Medical UniversityNational Science CouncilEuropean Cooperation in Science and TechnologyUnited Soybean BoardBarbara Ann Karmanos Cancer InstituteAl Jalila FoundationJackson State University
Mots-clés
NecroptosisApoptosisCancerCancer researchCancer cellProgrammed cell deathSignal transductionAutophagyXIAPBiologyCell biologyCaspase
Résumé présent dans OpenAlex
oui